These are expected GLP-1 side effects related to the mechanism of action
Individual variation in GLP-1 receptor density and sensitivity, baseline insulin resistance, metabolic rate, body composition, genetic factors affecting drug metabolism, concurrent medications or supplements, adherence to dietary and lifestyle recommendations, and starting weight all influence how quickly and dramatically you respond to semaglutide
Cardiovascular history Semaglutide has extensive cardiovascular outcome data, including the SELECT trial showing a 20% reduction in heart attacks and strokes in people with obesity
Eli Lilly: No Big Gap To Competition Summary Eli Lilly leads the GLP-1 market with superior current products but faces intensifying competition from Novo Nordisk and others
As a primary care and concierge medical clinic, we combine clinical rigor with a personalized experience, ensuring you feel heard and cared for every step of the way
If youre unsure your provider will help you decide during your consult